# FDA recall D-0705-2017

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2017-04-24.

## Product

Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 9777600, Israel

## Reason for recall

Microbial Contamination of Non-Sterile Products

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0705-2017
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-04-24
- **Report date:** 2017-05-17
- **Termination date:** 2018-02-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0705-2017

## Citation

> AI Analytics. FDA recall D-0705-2017. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-0705-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*